1. Home
  2. CTXR vs HYFM Comparison

CTXR vs HYFM Comparison

Compare CTXR & HYFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTXR
  • HYFM
  • Stock Information
  • Founded
  • CTXR 2007
  • HYFM 1977
  • Country
  • CTXR United States
  • HYFM United States
  • Employees
  • CTXR N/A
  • HYFM N/A
  • Industry
  • CTXR Biotechnology: Pharmaceutical Preparations
  • HYFM Industrial Machinery/Components
  • Sector
  • CTXR Health Care
  • HYFM Industrials
  • Exchange
  • CTXR Nasdaq
  • HYFM Nasdaq
  • Market Cap
  • CTXR 20.8M
  • HYFM 17.3M
  • IPO Year
  • CTXR N/A
  • HYFM 2020
  • Fundamental
  • Price
  • CTXR $1.13
  • HYFM $3.18
  • Analyst Decision
  • CTXR Strong Buy
  • HYFM
  • Analyst Count
  • CTXR 3
  • HYFM 0
  • Target Price
  • CTXR $53.00
  • HYFM N/A
  • AVG Volume (30 Days)
  • CTXR 473.1K
  • HYFM 22.2K
  • Earning Date
  • CTXR 08-12-2025
  • HYFM 11-06-2025
  • Dividend Yield
  • CTXR N/A
  • HYFM N/A
  • EPS Growth
  • CTXR N/A
  • HYFM N/A
  • EPS
  • CTXR N/A
  • HYFM N/A
  • Revenue
  • CTXR N/A
  • HYFM $161,102,000.00
  • Revenue This Year
  • CTXR N/A
  • HYFM $5.45
  • Revenue Next Year
  • CTXR $851.67
  • HYFM $5.33
  • P/E Ratio
  • CTXR N/A
  • HYFM N/A
  • Revenue Growth
  • CTXR N/A
  • HYFM N/A
  • 52 Week Low
  • CTXR $0.65
  • HYFM $1.50
  • 52 Week High
  • CTXR $15.25
  • HYFM $8.55
  • Technical
  • Relative Strength Index (RSI)
  • CTXR 39.44
  • HYFM 32.76
  • Support Level
  • CTXR $1.10
  • HYFM $2.65
  • Resistance Level
  • CTXR $1.25
  • HYFM $3.30
  • Average True Range (ATR)
  • CTXR 0.09
  • HYFM 0.30
  • MACD
  • CTXR -0.01
  • HYFM -0.11
  • Stochastic Oscillator
  • CTXR 8.49
  • HYFM 27.25

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

About HYFM Hydrofarm Holdings Group Inc.

Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.

Share on Social Networks: